{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:03:28Z","timestamp":1752282208335,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41433-020-01188-0","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:02:56Z","timestamp":1602234176000},"page":"289-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Blind patients in end-stage inherited retinal degeneration: multimodal imaging of candidates for artificial retinal prosthesis"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6664-1327","authenticated-orcid":false,"given":"Lorenzo","family":"Iuliano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Fogliato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Corbelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Codenotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"1188_CR1","doi-asserted-by":"publisher","first-page":"e004015","DOI":"10.1136\/bmjopen-2013-004015","volume":"4","author":"G Liew","year":"2014","unstructured":"Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014;4:e004015.","journal-title":"BMJ Open"},{"key":"1188_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/138920211795860107","volume":"12","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genom. 2011;12:238\u201349.","journal-title":"Curr Genom"},{"key":"1188_CR3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/ceo.13458","volume":"47","author":"M Iftikhar","year":"2019","unstructured":"Iftikhar M, Usmani B, Sanyal A, Kherani S, Sodhi S, Bagheri S, et al. Progression of retinitis pigmentosa on multimodal imaging: the PREP-1 study. Clin Exp Ophthalmol. 2019;47:605\u201313.","journal-title":"Clin Exp Ophthalmol"},{"key":"1188_CR4","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/S0161-6420(99)90342-1","volume":"106","author":"S Grover","year":"1999","unstructured":"Grover S, Fishman GA, Anderson RJ, Tozatti MSV, Heckenlively JR, Weleber RG, et al. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology. 1999;106:1780\u20135.","journal-title":"Ophthalmology."},{"key":"1188_CR5","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0161-6420(96)30458-2","volume":"103","author":"S Grover","year":"1996","unstructured":"Grover S, Fishman GA, Alexander KR, Anderson RJ, Derlacki DJ. Visual acuity impairment in patients with retinitis pigmentosa. Ophthalmology. 1996;103:1593\u2013600.","journal-title":"Ophthalmology."},{"key":"1188_CR6","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JWB Bainbridge","year":"2008","unstructured":"Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, et al. Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358:2231\u20139.","journal-title":"N Engl J Med"},{"key":"1188_CR7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","volume":"383","author":"RE MacLaren","year":"2014","unstructured":"MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, et al. Retinal gene therapy in patients with choroideremia: Initial findings from a phase 1\/2 clinical trial. Lancet. 2014;383:1129\u201337.","journal-title":"Lancet."},{"key":"1188_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","volume":"388","author":"J Bennett","year":"2016","unstructured":"Bennett J, Wellman J, Marshall KA, McCague S, Ashtari M, DiStefano-Pappas J, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016;388:661\u201372.","journal-title":"Lancet"},{"key":"1188_CR9","doi-asserted-by":"crossref","unstructured":"Prado DA, Acosta-Acero M, Maldonado RS. Gene therapy beyond luxturna: a new horizon of the treatment for inherited retinal disease. Curr Opin Ophthalmol. 2020;31:147\u201354.","DOI":"10.1097\/ICU.0000000000000660"},{"key":"1188_CR10","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1167\/iovs.10-6932","volume":"52","author":"A Schatz","year":"2011","unstructured":"Schatz A, R\u00f6ck T, Naycheva L, Willmann G, Wilhelm B, Peters T, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Investig Ophthalmol Vis Sci. 2011;52:4485\u201396.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1188_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1167\/iovs.16-19906","volume":"58","author":"A Schatz","year":"2017","unstructured":"Schatz A, Pach J, Gosheva M, Naycheva L, Willmann G, Wilhelm B, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled follow-up study over 1 year. Investig Ophthalmol Vis Sci. 2017;58:257\u201369.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1188_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/gt.2011.155","volume":"19","author":"V Busskamp","year":"2012","unstructured":"Busskamp V, Picaud S, Sahel JA, Roska B. Optogenetic therapy for retinitis pigmentosa. Gene Ther. 2012;19:169\u201375.","journal-title":"Gene Ther"},{"key":"1188_CR13","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1073\/pnas.1119416110","volume":"110","author":"MS Singh","year":"2013","unstructured":"Singh MS, Charbel Issa P, Butler R, Martin C, Lipinski DM, Sekaran S, et al. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci USA. 2013;110:1101\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1188_CR14","doi-asserted-by":"crossref","unstructured":"Scholl HPN, Moore AT, Koenekoop RK, Wen Y, Fishman GA, Van Den Born LI, et al. Safety and proof-of-concept study of oral QLT091001 in retinitis pigmentosa due to inherited deficiencies of retinal pigment epithelial 65 protein (RPE65) or lecithin: retinol acyltransferase (LRAT). PLoS ONE.\u00a02015;10:e0143846.","DOI":"10.1371\/journal.pone.0143846"},{"key":"1188_CR15","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1098\/rspb.2010.1747","volume":"278","author":"E Zrenner","year":"2011","unstructured":"Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, Bruckmann A, Gabel VP, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc R Soc B Biol Sci. 2011;278:1489\u201397.","journal-title":"Proc R Soc B Biol Sci"},{"key":"1188_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ophtha.2011.09.028","volume":"119","author":"MS Humayun","year":"2012","unstructured":"Humayun MS, Dorn JD, Da Cruz L, Dagnelie G, Sahel JA, Stanga PE, et al. Interim results from the international trial of second sight\u2019s visual prosthesis. Ophthalmology. 2012;119:779\u201388.","journal-title":"Ophthalmology."},{"key":"1188_CR17","doi-asserted-by":"crossref","unstructured":"Ayton LN, Blamey PJ, Guymer RH, Luu CD, Nayagam DAX, Sinclair NC, et al. First-in-human trial of a novel suprachoroidal retinal prosthesis. PLoS ONE. 2014;9:e115239.","DOI":"10.1371\/journal.pone.0115239"},{"key":"1188_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.visres.2015.03.001","volume":"111","author":"K Stingl","year":"2015","unstructured":"Stingl K, Bartz-Schmidt KU, Besch D, Chee CK, Cottriall CL, Gekeler F, et al. Subretinal visual implant alpha IMS-clinical trial interim report. Vis Res. 2015;111:149\u201360.","journal-title":"Vis Res"},{"key":"1188_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nmat4874","volume":"16","author":"JF Maya-Vetencourt","year":"2017","unstructured":"Maya-Vetencourt JF, Ghezzi D, Antognazza MR, Colombo E, Mete M, Feyen P, et al. A fully organic retinal prosthesis restores vision in a rat model of degenerative blindness. Nat Mater. 2017;16:681\u20139.","journal-title":"Nat Mater"},{"key":"1188_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fnins.2017.00445","volume":"11","author":"K Stingl","year":"2017","unstructured":"Stingl K, Schippert R, Bartz-Schmidt KU, Besch D, Cottriall CL, Edwards TL, et al. Interim results of a multicenter trial with the new electronic subretinal implant alpha AMS in 15 patients blind from inherited retinal degenerations. Front Neurosci. 2017;11:445.","journal-title":"Front Neurosci"},{"key":"1188_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ophtha.2017.09.019","volume":"125","author":"TL Edwards","year":"2018","unstructured":"Edwards TL, Cottriall CL, Xue K, Simunovic MP, Ramsden JD, Zrenner E, et al. Assessment of the electronic retinal implant alpha AMS in restoring vision to blind patients with end-stage retinitis pigmentosa. Ophthalmology. 2018;125:432\u201343.","journal-title":"Ophthalmology."},{"key":"1188_CR22","doi-asserted-by":"publisher","first-page":"210ps16","DOI":"10.1126\/scitranslmed.3007399","volume":"5","author":"E Zrenner","year":"2013","unstructured":"Zrenner E. Fighting blindness with microelectronics. Sci Transl Med. 2013;5:210ps16.","journal-title":"Sci Transl Med"},{"key":"1188_CR23","unstructured":"Bach M. Freiburg visual acuity & contrast test (FrACT). 2002. https:\/\/michaelbach.de\/fract\/index.html."},{"key":"1188_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg Visual Acuity Test. Investig Ophthalmol Vis Sci. 2006;47:1236\u201340.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1188_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3758\/BF03202110","volume":"14","author":"HR Lieberman","year":"1982","unstructured":"Lieberman HR, Pentland AP. Microcomputer-based estimation of psychophysical thresholds: The Best PEST. Behav Res Methods Instrum. 1982;14:21\u20135.","journal-title":"Behav Res Methods Instrum"},{"key":"1188_CR26","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/0042-6989(95)00016-X","volume":"35","author":"B Treutwein","year":"1995","unstructured":"Treutwein B. Adaptive psychophysical procedures. Vis Res. 1995;35:2503\u201322.","journal-title":"Vis Res"},{"key":"1188_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1163\/156856897X00087","volume":"11","author":"M Bach","year":"1997","unstructured":"Bach M. Anti-aliasing and dithering in the \u201cFreiburg Visual Acuity Test.\u201d. Spat Vis. 1997;11:85\u20139.","journal-title":"Spat Vis"},{"key":"1188_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.preteyeres.2017.08.004","volume":"62","author":"PA Campochiaro","year":"2018","unstructured":"Campochiaro PA, Mir TA. The mechanism of cone cell death in Retinitis Pigmentosa. Prog Retin Eye Res. 2018;62:24\u201337.","journal-title":"Prog Retin Eye Res"},{"key":"1188_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nn.2234","volume":"12","author":"C Punzo","year":"2009","unstructured":"Punzo C, Kornacker K, Cepko CL. Stimulation of the insulin\/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa. Nat Neurosci. 2009;12:44\u201352.","journal-title":"Nat Neurosci"},{"key":"1188_CR30","doi-asserted-by":"crossref","unstructured":"Wang AL, Knight DK, Vu TTT, Mehta MC. Retinitis pigmentosa: review of current treatment. Int Ophthalmol Clin. 2019;59:263\u201380.","DOI":"10.1097\/IIO.0000000000000256"},{"key":"1188_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000351681","volume":"50","author":"G Triolo","year":"2013","unstructured":"Triolo G, Pierro L, Parodi MB, De Benedetto U, Gagliardi M, Manitto MP, et al. Spectral domain optical coherence tomography findings in patients with retinitis pigmentosa. Ophthalmic Res. 2013;50:160\u20134.","journal-title":"Ophthalmic Res"},{"key":"1188_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.oret.2017.07.020","volume":"2","author":"Y Nagasaka","year":"2018","unstructured":"Nagasaka Y, Ito Y, Ueno S, Terasaki H. Number of hyperreflective foci in the outer retina correlates with inflammation and photoreceptor degeneration in retinitis pigmentosa. Ophthalmol Retin. 2018;2:726\u201334.","journal-title":"Ophthalmol Retin"},{"key":"1188_CR33","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1097\/IAE.0000000000001256","volume":"36","author":"K Schuerch","year":"2016","unstructured":"Schuerch K, Marsiglia M, Lee W, Tsang SH, Sparrow JR. Multimodal imaging of disease-associated pigmentary changes in retinitis pigmentosa. Retina. 2016;36:S147\u201358.","journal-title":"Retina."},{"key":"1188_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.eye.6703076","volume":"23","author":"S Aizawa","year":"2009","unstructured":"Aizawa S, Mitamura Y, Baba T, Hagiwara A, Ogata K, Yamamoto S. Correlation between visual function and photoreceptor inner\/outer segment junction in patients with retinitis pigmentosa. Eye. 2009;23:304\u20138.","journal-title":"Eye"},{"key":"1188_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1167\/iovs.12-10149","volume":"54","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Joe SG, Lee DH, Lee JY, Kim JG, Yoon YH. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Investig Ophthalmol Vis Sci. 2013;54:1303\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1188_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00417-018-4185-4","volume":"257","author":"K Sousa","year":"2019","unstructured":"Sousa K, Fernandes T, Gentil R, Mendon\u00e7a L, Falc\u00e3o M. Outer retinal layers as predictors of visual acuity in retinitis pigmentosa: a cross-sectional study. Graefe\u2019s Arch Clin Exp Ophthalmol. 2019;257:265\u201371.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"1188_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/IAE.0b013e3181c596e3","volume":"30","author":"SF Oster","year":"2010","unstructured":"Oster SF, Mojana F, Brar M, Yuson RMS, Cheng L, Freeman WR. Disruption of the photoreceptor inner segment\/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina. 2010;30:713\u20138.","journal-title":"Retina."},{"key":"1188_CR38","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00417-015-3185-x","volume":"254","author":"M Battaglia Parodi","year":"2016","unstructured":"Battaglia Parodi M, La Spina C, Triolo G, Riccieri F, Pierro L, Gagliardi M, et al. Correlation of SD-OCT findings and visual function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2016;254:1275\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1188_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00417-019-04516-7","volume":"258","author":"EN Cetin","year":"2020","unstructured":"Cetin EN, Parca O, Akkaya HS, Pekel G. Association of retinal biomarkers and choroidal vascularity index on optical coherence tomography using binarization method in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2020;258:23\u201330.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1188_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2017.06.023","volume":"181","author":"A Govetto","year":"2017","unstructured":"Govetto A, Su D, Farajzadeh M, Megerdichian A, Platner E, Ducournau Y, et al. Microcystoid macular changes in association with idiopathic epiretinal membranes in eyes with and without glaucoma: clinical insights. Am J Ophthalmol. 2017;181:156\u201365.","journal-title":"Am J Ophthalmol"},{"key":"1188_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/IAE.0000000000000780","volume":"36","author":"R Dolz-Marco","year":"2016","unstructured":"Dolz-Marco R, Hoang QV, Gallego-Pinazo R, Chang S, ASSESSMENT OF. The significance of cystic changes after epiretinal membrane surgery with internal limiting membrane removal. Retina. 2016;36:727\u201332.","journal-title":"Retina."},{"key":"1188_CR42","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1167\/iovs.13-12912","volume":"55","author":"MC Burggraaff","year":"2014","unstructured":"Burggraaff MC, Trieu J, de Vries-Knoppert WAEJ, Balk L, Petzold A. The clinical spectrum of microcystic macular edema. Investig Ophthalmol Vis Sci. 2014;55:952\u201361.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1188_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ophtha.2013.08.045","volume":"121","author":"M Abegg","year":"2014","unstructured":"Abegg M, Dysli M, Wolf S, Kowal J, Dufour P, Zinkernagel M. Microcystic macular edema: Retrograde maculopathy caused by optic neuropathy. Ophthalmology. 2014;121:142\u20139.","journal-title":"Ophthalmology."},{"key":"1188_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/IAE.0000000000000692","volume":"36","author":"G Querques","year":"2016","unstructured":"Querques G, Kamami-Levy C, Georges A, Pedinielli A, Capuano V, Blanco-Garavito R, et al. Adaptive optics imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Retina. 2016;36:247\u201354.","journal-title":"Retina."},{"key":"1188_CR45","doi-asserted-by":"crossref","unstructured":"Fleckenstein M, Mitchell P, Freund KB, Sadda SV, Holz FG, Brittain C, et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125:369\u201390.","DOI":"10.1016\/j.ophtha.2017.08.038"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01188-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:16:08Z","timestamp":1696850168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01188-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-01188-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"LI, GF, EC and MC: none. FB reports personal fees from Alcon (Fort Worth, TX, USA), personal fees from Alimera Sciences (Alpharetta, GA, USA), personal fees from Allergan Inc (Irvine, CA, USA), personal fees from Farmila-Thea (Clermont-Ferrand, France), personal fees from Bayer Shering-Pharma (Berlin, Germany), personal fees from Bausch And Lomb (Rochester, NY, USA), personal fees from Genentech (San Francisco, CA, USA), personal fees from Hoffmann-La-Roche (Basel, Switzerland), personal fees from NovagaliPharma (\u00c9vry, France), personal fees from Novartis (Basel, Switzerland), personal fees from Sanofi-Aventis (Paris, France), personal fees from Thrombogenics (Heverlee,Belgium), personal fees from Zeiss (Dublin, USA), outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}